INDV
Indivior Plc

227
Mkt Cap
$4.06B
Volume
2.36M
52W High
$38.00
52W Low
$7.62
PE Ratio
32.40
INDV Fundamentals
Price
$32.54
Prev Close
$32.89
Open
$33.10
50D MA
$34.11
Beta
0.77
Avg. Volume
3.28M
EPS (Annual)
$0.015
P/B
-19.65
Rev/Employee
$1.13M
Loading...
Loading...
News
all
press releases
Ritholtz Wealth Management Buys Shares of 92,845 Indivior PLC $INDV
Ritholtz Wealth Management purchased a new position in shares of Indivior PLC (NASDAQ:INDV - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·20h ago
News Placeholder
More News
News Placeholder
Short Interest in Indivior PLC (NASDAQ:INDV) Rises By 57.5%
Indivior PLC (NASDAQ:INDV - Get Free Report) saw a large increase in short interest in December. As of December 31st, there was short interest totaling 10,322,427 shares, an increase of 57.5% from...
MarketBeat·2d ago
News Placeholder
Indivior (NASDAQ:INDV) Downgraded to "Hold" Rating by Zacks Research
Zacks Research cut Indivior from a "strong-buy" rating to a "hold" rating in a research report on Tuesday...
MarketBeat·4d ago
News Placeholder
Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes
SNY wins EU approval for Teizeild, the first disease-modifying drug to delay stage 3 type 1 diabetes in adults and children aged eight and older.
Zacks·6d ago
News Placeholder
HC Wainwright Estimates Indivior's Q2 Earnings (NASDAQ:INDV)
Indivior PLC (NASDAQ:INDV - Free Report) - Equities researchers at HC Wainwright issued their Q2 2026 EPS estimates for shares of Indivior in a research note issued on Monday, January 12th. HC...
MarketBeat·6d ago
News Placeholder
51,426 Shares in Indivior PLC $INDV Purchased by KLP Kapitalforvaltning AS
KLP Kapitalforvaltning AS bought a new stake in shares of Indivior PLC (NASDAQ:INDV - Free Report) in the third quarter, according to its most recent Form 13F filing with the SEC. The fund bought...
MarketBeat·6d ago
News Placeholder
Indivior PLC (NASDAQ:INDV) Given Average Recommendation of "Buy" by Analysts
Indivior PLC (NASDAQ:INDV - Get Free Report) has earned an average recommendation of "Buy" from the nine ratings firms that are presently covering the firm, Marketbeat Ratings reports. One equities...
MarketBeat·6d ago
News Placeholder
PCRX Stock Down 10% as Preliminary Q4 Revenues Miss Estimates
Pacira BioSciences stock slides nearly 10% after preliminary Q4 revenues of $196.9 million miss estimates, despite Exparel sales topping forecasts.
Zacks·7d ago
News Placeholder
TEVA Signs Deal With RPRX to Accelerate Development of Vitiligo Drug
Teva strikes a $500M funding deal with Royalty Pharma for the speedy development of its vitiligo candidate, TEV-'408, while keeping global commercial control.
Zacks·7d ago
News Placeholder
Take the Zacks Approach to Beat the Markets: Indivior, FIGS & Ulta Beauty in Focus
Zacks highlights how Indivior, FIGS and Ulta Beauty delivered outsized gains as its ranks, recommendations and focus lists beat a volatile market.
Zacks·7d ago
<
1
2
...
>

Latest INDV News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.